• Info
  • Insider Ownership

Insider Trading & Ownership of Jeffrey V Poulton

Location
Cambridge, MA
Summary
The estimated net worth of Jeffrey V Poulton is at least $20,920,825 dollars as of 06 Mar 2026. Jeffrey V Poulton is the EVP, Chief Financial Officer of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $20.61M. Jeffrey V Poulton is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $308.7K.
Signature
By: Brett Budzinski, Attorney-in-Fact For: Jeffrey V. Poulton
All Insider Reports
All Insider Reports

Notify me when Jeffrey V Poulton files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Jeffrey V Poulton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer $20,612,165 -$5,982,129 -22% 04 Mar 2026
QTTB Homology Medicines, Inc. Director $308,660 14 Jun 2023
CRVO CervoMed Inc. Director 23 Jun 2025

Insider Transactions Reported by Jeffrey V Poulton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.